Select country set
Menu Shopping cart 0,00 Search
Manufactured by BioVendor

GDF-5 (BMP-14/CDMP-1) Human E. coli

  • Regulatory status:RUO
  • Type:Recombinant protein
  • Source:E. coli
  • Other names:BMP-14/CDMP-1, BMP-14, Cartilage-Derived Morphogenetic Protein-1 (CDMP-1)
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RBG10161010 10 µg
RBG10161050 50 µg
RBG10161100 100 μg
PubMed Product Details
Technical Data


Recombinant protein


GDF-5 is expressed in long bones during embryonic development and postnatally in articular cartilage. Mutations in the GDF-5 gene have been implicated in Hunter-Thompson type dwarfism and in Grebe Syndrome, which is characterized by short stature, extra digits, and short and deformed extremities. The mature and functional form of GDF-5 is a homodimer of two 120 amino-acid polypeptide chain (monomers) linked by a single disulfide bond. Each GDF-5 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 27 amino acid signal peptide and a 354 amino acid propeptide. This precursor undergoes intracellular dimerization, and upon secretion it is processed by a furin-type protease. Recombinant Human GDF-5 is a 27.0 kDa homodimeric disulfide-linked protein consisting of two 120 amino acid polypeptide chains. License: This product is produced solely by PeproTech Inc. under a license from Biopharm GmbH, Germany. Biopharm GmbH is not responsible for the quality or fitness for use of this product. It may be used only for research purposes and may neither be used in humans nor for veterinary purposes. This product may not be used for commercial purposes.

Amino Acid Sequence



E. coli



Biological Activity

The ED 50 was determined by its ability to induce alkaline phosphatase production by ATDC-5 chondrogenic cells is 1.0–2.0 µg/ml.


Endotoxin level is <0.1 ng/μg of protein (<1EU/μg).


Centrifuge the vial prior to opening. Reconstitute in water containing BSA (50ug of BSA per 1ug of protein) to a concentration of 0.1–1.0 mg/ml. Do not vortex. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at –20°C to –80°C.




Research topic

Cardiovascular disease, Extracellular matrix, Others

Related Products Docs